Back

Lipoprotein(a) and autotaxin in patients with stenotic atherosclerosis of coronary arteries and aortic valve stenosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease Aortic Valve Disease, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Marat Ezhov

Russian Cardiology Research and Production Complex, Moscow (Russian Federation)

9 More presentations in this session

Presentation thumbnail
Age distribution of valvular heart disease in China: from a national multicenter prospective cohort study
Doctor H. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Trends in rheumatic heart disease in Egypt (2006-2018): data from the national rheumatic heart prevention and control program
Doctor A. El Ghamrawy (Almahalla Alkobra, EG)
Abstract Slides
Presentation thumbnail
Survival of people with valvular heart disease in the community (OxValve-Survive)
Associate Professor S. Myerson (Oxford, GB)
Abstract Slides
Presentation thumbnail
Identification of microRNAs in aortic valve calcification patients with bicuspid aortic valve
Doctor Z. meng (Beijing, CN)
Abstract
Presentation thumbnail
PCSK9 and HS-CRP are predictors of the progression of aortic stenosis in patients with stable coronary artery.
Doctor A. Acena Navarro (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources